Purple Biotech (XTAE:PPBT) Stock Based Compensation : ₪7.16 Mil (TTM As of Dec. 2023)

View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech Stock Based Compensation?

Purple Biotech's Stock Based Compensation for the three months ended in Dec. 2023 was ₪0.69 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₪7.16 Mil.

Purple Biotech Stock Based Compensation Historical Data

The historical data trend for Purple Biotech's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Stock Based Compensation Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

4.86

10.14

7.96

9.23

7.20

Purple Biotech Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Stock Based Compensation	Get a 7-Day Free Trial															3.22	2.87	1.88	1.72	0.69

Purple Biotech Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪7.16 Mil.

Purple Biotech Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

PPBT:USA 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.